Drug Regulation
Drug Control Governance: Regulatory Bodies and Their Impact
Clinical Trials: Overview
Preclinical Development: Overview
Drug Administration and Therapy Phases: Overview
Clinical Trials
您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Pamela D Scott1, Anita Bajaj2, David P McMullen2
1Food and Drug Administration, Center for Devices and Radiological Health, Office of Product Evaluation and Quality, Office of Neurological and Physical Medicine Devices, 10903 New Hampshire Ave., Silver Spring, MD, 20993, USA. PamelaD.Scott@fda.hhs.gov.
新型医疗设备为神经精神疾病提供了快速治疗. 这一观点回顾了FDA对神经调节器件的监管途径,强调了开发人员的早期参与和患者投入.
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: